Welcome to our dedicated page for Ecolab news (Ticker: ECL), a resource for investors and traders seeking the latest updates and insights on Ecolab stock.
Ecolab Inc. reports developments in water, hygiene and infection prevention solutions and services for customers across food, healthcare, data centers, microelectronics, life sciences, hospitality and other industrial markets. Company news commonly covers operating results, dividends, annual-meeting matters, pricing and cost actions, and updates to its global service model.
Product and business updates include AI-enabled water intelligence tools such as Ecolab Water Navigator IQ, Life Sciences bioprocessing capabilities, purification technologies and applications labs, and water-management and sanitation offerings used in customer operations. News also tracks capital-return actions, supply-chain cost responses and governance disclosures tied to its common stock.
Ecolab's 2024 Watermark™ Study reveals significant shifts in consumer behavior due to water concerns. Key findings include:
1. Consumers in China (80%), IMEA (69%), and Latin America (65%) have stopped buying products that use excessive water.
2. A majority across all regions are willing to pay a 1-4% premium for sustainably produced products.
3. Access to clean and safe water remains a top concern, especially in Latin America (90%), China (88%), and the US (80%).
4. Consumers hold businesses and governments most responsible for water conservation but doubt their commitment.
5. Urban consumers show increased concern about climate change compared to rural counterparts.
The study highlights the growing importance of water stewardship in consumer decision-making and business strategies.
Ecolab (ECL) has announced a live webcast to discuss its 2024 third quarter results. The event is scheduled for Tuesday, October 29, 2024, at 1:00 p.m. Eastern Time and will last for one hour. Ecolab plans to release its Q3 results before the market opens on October 29th.
The webcast will be accessible through www.ecolab.com/investor. For those unable to attend the live event, Ecolab will provide a replay of the webcast and supplemental data on their website. This announcement demonstrates Ecolab's commitment to transparency and keeping investors informed about their financial performance.
Ecolab Inc. (ECL) has announced a regular quarterly cash dividend of $0.57 per common share. The dividend will be paid on October 15, 2024, to shareholders of record at the close of business on September 17, 2024. This announcement continues Ecolab's impressive track record of paying cash dividends for 87 consecutive years, demonstrating the company's commitment to returning value to shareholders and its financial stability.
Ecolab Inc. has closed the sale of its global surgical solutions business to Medline for approximately $950 million in cash. The company plans to repurchase up to $500 million of its stock during the second half of 2024. Ecolab will continue serving hospitals through its infection prevention and instrument reprocessing businesses.
The sale proceeds will enhance Ecolab's ability to invest in growth opportunities and return capital to shareholders. The company expects to repurchase shares in the open market, through privately negotiated transactions, and in accordance with Rule 10b5-1. As of June 30, 2024, Ecolab had approximately 285 million shares outstanding.
Ecolab (ECL) reported strong Q2 2024 results with sales of $4.0 billion, up 3% year-over-year. Organic sales grew 4%, driven by a 7% increase in the Institutional & Specialty segment. Adjusted diluted EPS rose 35% to $1.68. The company increased its full-year 2024 adjusted EPS guidance to $6.50-$6.70, representing 25-29% growth.
Key highlights include:
- Operating income margin expanded 360 bps to 17.0% on an organic basis
- Free cash flow increased to $414 million
- Launched 'One Ecolab' initiative to drive growth and operational efficiencies
- Expects Q3 2024 adjusted EPS of $1.75-$1.85, up 14-20% year-over-year
Ecolab continues to outperform soft macroeconomic trends through market share gains, innovation, and operational improvements.
Ecolab will host a live webcast to discuss its Q2 2024 earnings on July 30, 2024. The webcast will begin at 1:00 p.m. Eastern Time and last for one hour. A news release containing the Q2 results will be issued before the market opens on the same day. The webcast can be accessed at www.ecolab.com/investor, and a replay along with supplemental data will be available on the site.
Ecolab, in partnership with Repligen , announced the commercial launch of DurA Cycle Affinity Resin, designed for large-scale purification in biologic manufacturing. This product, launched at BIO 2024 in San Diego, targets efficient monoclonal antibody production, reducing costs for biologic drug developers. The launch reflects Ecolab's ongoing commitment to bioprocessing innovations, following two other resins launched in the past eighteen months. The partnership aims to address complex challenges in biologic manufacturing and is bolstered by Ecolab's investment in a new production facility in Landenberg, PA, complementing its UK-based facility.
Ecolab will webcast a presentation by its Chairman and CEO, Christophe Beck, at the William Blair Growth Stock Conference on June 4, 2024. The event will start at 11:40 a.m. Eastern Time and will last for about 30 minutes. This webcast will be accessible via Ecolab's investor website, with a replay available until June 28, 2024.
Ecolab has released its 2023 Growth & Impact Report, highlighting its economic, environmental, social, and governance achievements. The report details significant progress toward Ecolab's 2030 Positive Impact goals. Key milestones in 2023 include conserving 226 billion gallons of water, providing safe food to 1.4 billion people, and avoiding 3.8 million metric tons of greenhouse gas emissions. Ecolab also reached 100% renewable electricity in its European operations and advanced its electric vehicle conversion efforts in North America. Additional achievements include AWS certifications in Monterrey and Nanjing, donating $18.5 million to global communities, and launching the California Water Resilience Initiative. These accomplishments underscore Ecolab's mission to integrate science-based solutions, enhance business health, and drive sustainability.
Ecolab and HeiQ Chrisal collaborate to launch Maxx Synbiotic cleaning products at Interclean in Amsterdam, introducing advanced synbiotic cleaning technology to the European market. The products deliver immediate, microscopic-level cleaning, efficient odor reduction, and support for a well-balanced microbiome on surfaces. HeiQ's technology has been validated in scientific studies, offering a promising future for the cleaning industry.